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Mitochondrial calcium (Ca2+) uptake is critical for regulating energy metabolism and mitochondrial 
movement, as well as buffering of intracellular Ca2+. This Ca2+ uptake is mediated by a highly selective 
Ca2+ pore complex composed of mitochondrial calcium uniporter (MCU), the inner mitochondrial 
membrane protein, and its regulatory proteins. Although the mechanism how MCU and its regulatory 
components regulate mitochondrial Ca2+ uptake is well established, a mechanism underlying the 
regulation of mitochondrial movement by MCU still remain unrevealed. Our previous work found 
mitochondrial Ca2+ content mediated by MCU is a critical factor for regulating the mitochondrial 
mobility in axon. Here, we find MCU interacts with mitochondrial Rho GTPase 1 (Miro1), known to 
regulate the mitochondrial mobility. We identify MCU’s N-terminal domain, previously known as 
mitochondrial targeting sequence (MTS), is essential for interaction with Miro1. Our results reveal N-
terminus of MCU contains a potential transmembrane domain that makes it possible to interact with 
Miro1, however, is not required for the localization of MCU into mitochondria. Furthermore, our data 
shows the elevation of intracellular Ca2+ triggers the cleavage of N-terminal domain of MCU, altering 
the interaction with Miro1, and this Ca2+-dependent MCU-Miro1 interaction is necessary to facilitate 
the axonal mitochondrial mobility. Together, our findings reveal a novel functional relationship between 
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Ⅰ. Introduction 
Mitochondrion is an essential organelle for neuronal functions and survival. 
Mitochondria, double membrane-bound organelles, are found in almost all types of eukaryotic cell1. 
It plays a vital role in synthesizing the adenosine triphosphate (ATP), known to the molecular unit of 
intracellular energy current, mainly through oxidative phosphorylation (OxPhos)2. In addition to its role 
as the power plant of the cell, mitochondria have a key role in regulating the intracellular calcium 
homeostasis3. These mitochondrial calcium buffering is critically important for both the mitochondrial 
metabolic activity and the control of calcium-dependent signaling pathway4-6. In the central nervous 
system (CNS) where a great amount of energy and sophisticated regulation of Ca2+ homeostasis are 
demanded7, mitochondrial functions are of importance to neurons. In particular, appropriate 
mitochondrial transport and distribution within two highly polarized compartments, dendrites and axon, 
are essential for supplying energy to these sites of neurons8. As a result, mitochondrial functions are 
directly linked to neuronal function and health. Also, mitochondrial dysfunctions, involving reductions 
in ATP synthesis, abnormal mitochondrial dynamics and morphology, and impaired mitochondrial 
transport, are commonly observed in various neurological diseases, such as Alzheimer’s disease (AD), 
Huntington’s disease (HD), Parkinson’s disease (PD), Schizophrenia (SCZ), and Multiple sclerosis 
(MS).9,10. Although loss of mitochondrial functions in some of neurological diseases may be a secondary 
or acquired effect obtained from primary sources, there is no doubt that pathogenesis of neurological 
disorders is exacerbated by defects in mitochondrial functions.11 
 
Mitochondrial Ca2+ regulates both mitochondrial energy metabolism and transport in neurons. 
Ca2+ is a ubiquitous second messenger which regulates a variety of biological processes in all 
eukaryotic cells12. These processes include the control of gene transcription, metabolism, cell mobility, 
cell growth, and programmed cell death, called apoptosis12. In neurons, Ca2+ is particularly important 
for regulating neurotransmitter release and membrane excitability for the synaptic transmission13,14. Due 
to its importance as a signaling molecule, extracellular Ca2+ influx across the plasma membrane, and 
intracellular Ca2+ storage/release are actively regulated by a large number of membrane transport 
proteins and subcellular organelles, involving sarcoplasmic/endoplasmic reticulum (SR/ER) and 
mitochondria15. Although ER is considered to be a main cellular compartment for Ca2+ storage and 
release, mitochondria also play a critical role in modulating intracellular Ca2+ as the calcium 
storage/release organelle15. These Ca2+ uptake into the mitochondria matrix allows mitochondria to be 
capable of their functions, involving the mitochondrial energy metabolism, and the mitochondrial 
movement in neurons16-18. The activity of three mitochondrial dehydrogenases, pyruvate dehydrogenase 
(PDH), α -ketoglutarate dehydrogenase ( α-KGDH) , and isocitrate dehydrogenase (ICDH) in the 
tricarboxylic acid (TCA) cycle is stimulated by mitochondrial Ca2+19. And our previous study found 
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mitochondrial Ca2+ acts as an internal signal to modulate mitochondrial transport, resulting in the 
redistribution of mitochondria within axons20. Imaging analysis of axonal mitochondria with Ca2+ 
indicator showed the inverse correlation between the speed of mitochondrial movement and the 
mitochondrial Ca2+ content20. It suggested mitochondrial Ca2+ can be a critical factor which facilitates 
the energy supply to proper sites by modulating mitochondrial distribution. 
 
Molecular identity and mechanism of MCU complex for mitochondrial Ca2+ uptake. 
Ca2+ uptake into mitochondrial matrix is tightly regulated by the MCU complex, a Ca2+-selective 
channel, across the inner mitochondrial membrane (IMM)21,22. This complex is comprised of MCU, the 
essential pore-forming subunit, and its regulatory subunits, including MCU paralogue (MCUb), 
mitochondrial calcium uptake protein 1-2 (MICU1-2), essential MCU regulator (EMRE), and MCU 
regulator 1 (MCUR1) (Figure 1B)23. The core subunit, MCU, is characterized by two TM domains, the 
DIME motif that is important for MCU activity, and two coiled-coil (CC) domains23 (Figure 1A). A 
recent study identified MCU forms a pentameric pore in which the second TM domain forms an inner 
core hydrophilic pore surrounded by the first TM domain24. The DIME motif forms the pore entrance 
exposed to the intermembrane space (IMS). And CC domains make a contribution to stabilize the pore 
assembly and structure24. MCUb, a paralogue of MCU, acts as its dominant-negative subunit. MCUb 
forms a hetero-oligomer with MCU, resulting in a decrease in Ca2+ uptake into mitochondrial matrix in 
response to the cytosolic Ca2+ elevation25. MICU1, as an activator or inhibitor of Ca2+ uptake through 
MCU complex, is found in the IMS26. It plays a critical role in preventing Ca2+ overload in the 
mitochondrial matrix. Highly conserved EF hand domain within MICU1 serves as a Ca2+-dependent 
gate sensor of MCU in response to the cytosolic Ca2+26. MICU2, its isoform, also has the conserved EF-
hand domain and forms a hetero-dimer with MICU127. MICU2, as the MCU gatekeeper, functions to 
inhibit the Ca2+ uptake into mitochondrial matrix at low cytosolic Ca2+28. EMRE, located in the IMM, 
is a metazoan-specific protein containing a single transmembrane (TM) domain29. It acts as a sensor of 
mitochondrial matrix Ca2+, allowing the MCU complex to inhibit Ca2+ uptake under normal condition29. 
EMRE interacts with MICU1 at the IMS, suggesting that EMRE functions cooperatively with 
MICU1/MICU2 to regulate the MCU activity in response to Ca2+ on both side of the IMM30. MCUR1 
interacts with MCU and EMRE, and is required for the MCU complex assembly as a scaffold factor31,32. 
 
Miro1 is an important component for regulating mitochondrial transport. 
Miro1 contains two GTPase domains, two EF hand Ca2+-binding domain between them, and a C-
terminal transmembrane domain for anchoring to the outer mitochondrial membrane (OMM)33 (Figure 
2A). Most part in Miro1 involving GTPase domains, and EF hand domains, is exposed on cytoplasmic 
side of the OMM34. The major function of Miro1 is the transport of mitochondria along microtubule 





Figure 1. Schematic domain of MCU and molecular structure of MCU complex. (A) Schematic 
diagram of functional domains of MCU. MCU is composed of putative mitochondrial targeting 
sequence (MTS), N-terminal domain (NTD), two coiled-coil domains (CC1, CC2), two transmembrane 
domains (TM1, TM2), and DIME motif flanked by transmembrane domains. (B) Molecular structure 
of MCU complex. MCU and MCUb as pore-forming subunits form a highly selective Ca2+ channel with 
the regulatory subunits, involving mitochondrial Ca2+ uptake protein 1, 2 (MICU1, MICU2), essential 
mitochondrial Ca2+ uniporter regulator (EMRE), and MCU regulator 1 (MCUR1). 
 
requires the efficient mitochondrial transport in response to physiological needs. In a mitochondrial 
transport machinery, Miro1 binds to the trafficking kinesin-binding protein 1-2 (TRAK1-2)36. The 
Miro1/TRAK complex sequentially interacts with kinesin or dynein motor proteins capable of the 
anterograde or retrograde mitochondrial movement, respectively36. Although the molecular identity and 
functions of these machinery components are well established, a detail mechanism underlying Ca2+-
dependent regulation of the motor/adaptor complex still remains unclear. Up to now, two models of 
Miro1 in regulating the mitochondrial mobility have been proposed37. The first proposed model is that 
Ca2+ binding to EF hands recruits kinesin to mitochondria by directly binding to the Miro1/TRAK 
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complex, preventing the motor from associating with microtubule tracts37 (Figure 2B [ⅰ]). The second 
model describes that the conformational change of Miro1 by Ca2+ binding to its EF hands allows 
mitochondria to dissociate from kinesin while TRAK1/2 remains bound to Miro1 with mitochondria37 
(Figure 2B [ⅱ]). Both models indicate mitochondrial movement is arrested by elevated intracellular 
Ca2+ in axon in which Miro1 acts as a Ca2+-dependent mediator through the conformational change 
upon Ca2+ binding to EF hands37. Several studies using Miro1 knock-out mouse model showed 




Figure 2. Schematic domain of Miro1 and model of Miro1 in regulating mitochondrial movement. 
(A) Schematic diagram of functional domains of Miro1. Miro1 is composed of two GTPase domains 
(GTPase1, GTPase2), two Ca2+-binding EF hands domains (EF1, EF2) flanked by GTPase domains, 
and a single transmembrane domain (TM) at C-terminus of Miro1. (B) Schematic models of Miro1 in 
regulating mitochondrial transport. [ⅰ] Ca2+ binding to Miro1’s EF hands triggers the dissociation of the 
motor protein, kinesin, from mitochondria, leading to detachment of the motor from microtubule tracts. 
[ⅱ] Ca2+ binding to the EF hands allows the kinesin to dissociate from Miro1, while the Miro1/TRAK 
complex still maintains the binding to mitochondria. 
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Ⅱ. Materials and Methods 
Animal Care. Animals were used in accordance with protocols approved by the Animal Care and 
Use Committees of UNIST. C57BL/6 mice were purchased from Hyochang Science (Korea). 
Coverslip Preparation. For microscopy experiments, glass bottom dishes (Cellvis, D35-14-1.5-N) 
and #1.5H coverslips (Deckglaser, ref 0117520) were immersed in 1M HCl for at least 4 hours at 55°C. 
Next, dishes were washed with autoclaved dH2O, followed by 50%, 70%, and 100% EtOH for 30 
minutes. After washing, dishes were dried in a biological safety cabinet with UV exposure for 
sterilization. Dried dishes were then coated with 1× PBS containing 50μg/ml of Poly-D-lysine (PDL, 
Thermo Fisher Scientific, P6407) in cell culture incubator overnight. PDL-coated dishes were washed 
three times with autoclaved dH2O, and dried in a biological safety cabinet. PDL-Coated dishes were 
stored in a cell culture incubator until use. 
Plasmid Preparation.  shMCU vector was purchased from Sigma-Aldrich (shMCU: 
TRCN0000251261). Myc-Miro1 plasmid vector was obtained from Dr. Pontus Aspenstrom. MCU was 
cloned into pFLAG-CMV6B vector (Sigma-Aldrich) using primers 5’CTGAATTCATATGGCGGCCG 
CCGCAGGTAG3’, and 5’GCTGGATCCTCATTCCTTTTCTCCGATCTG3’. C-Flag vector (Addgene, 
20011) and sfGFP-N1 vector (Addgene, 54737) were then used for MCU subcloning. TOMM20-Myc 
was cloned from TOMM20-sfGFP vector, which was subcloned from mEos3.2-TOMM20-N-10 vector 
(Addgene, 57483). sfGFP was replaced to Myc-tag using the primers 5’TCCGAGGAGGACCTGACC 
GGTGCGGCCGCGACTCTAGATCA3’, and 5’GATCAGCTTCTGCTCAGGATCCCCGCTACCGC 
CTTCCACATC3’. 
Cell Culture. E18 mouse embryos were used in all primary neuron culture. Pregnant mice euthanized 
in a CO2 Chamber were sacrificed by cervical dislocation. Embryos were immediately placed on a plate 
containing ice-cold HBSS (Thermo Fisher Scientific, 14065056). Hippocampi were isolated from 
embryonic brain, and washed twice with ice-cold HBSS (w/o Ca2+ and Mg2+). Trypsin without EDTA 
(Thermo Fisher Scientific, 15050065) was then added to hippocampi, and incubated for 15 minutes in 
a 37°C water bath. Next then, hippocampi were immediately transported into a tube containing FBS 
(Millipore, CAT# TMS-013-BKR) for inactivating trypsin, and washed twice with a trituration media, 
followed by pipetting up and down gently to cell dissociation. The dissociated cells filtered by 40μm 
cell strainer (Falcon, ref 352340) was then plated on PDL-coated coverslips or glass bottom dishes at a 
density of 0.035×106 cells/cm2. 3 hours after cell seeding, the trituration media was exchanged with a 
neuronal culture media composed of Neurobasal media (Thermo Fisher Scientific, 21103049), B27 
(Thermo Fisher Scientific, 17504044), and GlutaMAX (Thermo Fisher Scientific, 35050061). DMEM 
(Invitrogen) supplemented with 10% FBS and Penicillin/Streptomycin (Thermo Fisher Scientific, 
15070063) was used for maintaining HEK293 cells and N2A cells. For transfection into primary 
neurons, 1μl of Lipofectamine 2000 (Invitrogen) and 1.2μg of plasmid DNA were used with 100μl of 
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Opti-MEM. Lipofectamine 2000/DNA complexes were incubated for 20 minutes at room temperature. 
After then, half of the cell culture media was exchanged with the transfection media containing 
Lipofectamine 2000/DNA complexes. 3hour after transfection, the transfection media was replaced by 
a 50% mixture of old and fresh cell culture media. For cell lines, 2μl of Lipofectamine 2000 and 2μg of 
plasmid DNA were used with 200μl of Opti-MEM. Lipofectamine 2000/DNA complexes were 
incubated for 20 minutes at room temperature, and added to cell culture plates. There was no washout 
step after transfection. 
Mitochondrial Extraction. HEK293 cells were used for extracting mitochondria. First, cells were 
harvested by incubation into trypsin-EDTA for 5 minutes and centrifugation at 500× g at 4°C. Cell 
pellets were then washed twice with 1ml of 1× PBS, followed by resuspension in 1ml of ice-cold 
mitochondrial isolation buffer composed of 200mM Mannitol, 70mM Sucrose, 10mM HEPES pH7.4, 
1mM EGTA, and protease inhibitor cocktail. Cells were ruptured by 50-60 strokes with a douncer gently 
to avoid mitochondrial damage, and centrifuged twice at 700×g at 4°C. The pellet was removed, and 
supernatant containing intact mitochondria was centrifuged for 10 minutes at 10,000×g at 4°C to obtain 
purer mitochondrial fraction. For immunostaining of isolated mitochondria, mitochondrial pellet re-
suspended in 100μL of the isolation buffer was placed on coverslips. For Proteinase K experiments, the 
mitochondrial pellet was incubated with Proteinase K (Roche, 3115828001) diluted as 1:2000 in the 
isolation buffer for 10 minutes on ice. Before adhering mitochondria to coverslips, the mitochondrial 
pellet was washed twice with the ice-cold isolation buffer. 
Immunocytochemistry. Isolated mitochondria placed on prepared coverslips were incubated for 20 
minutes to adhere mitochondria to coverslips, followed by the fixation using 1×PBS containing 4% 
paraformaldehyde and 0.3% glutaraldehyde for 15 minutes at room temperature. Coverslips were 
incubated with 1mg/ml NaBH4 for 10 minutes to quench free amines. Fixed mitochondria were 
permeabilized with 1×PBS containing 0.3% triton-X for 10 minutes at room temperature, and blocked 
in 1×PBS containing 1% BSA and 0.05% sodium azide for 1 hour at room temperature. Coverslips were 
incubated with anti-FLAG antibody (Sigma, F7425) 1:500, anti-Myc antibody (Santa Cruz 
Biotechnologies, 9E10) 1:400, anti-TOMM20 antibody 1:200 (Abcam, ab56783), and anti-cytochrome 
C antibody 1:400 (BD Pharmingen Cat. 556433) diluted in the blocking solution at 4°C overnight. On 
the next day, coverslips were washed three times with PBST (0.1% TWEEN 20) for 10 minutes at room 
temperature. Secondary Alexa antibodies diluted as 1:400 in the blocking solution were incubated with 
coverslips for 2 hours at room temperature. After incubation, Coverslips were washed three times with 
PBST for 10 minutes at room temperature. Prolong Gold mounting reagent (Thermo Fisher Scientific, 
P36934) was used for mounting. For experiment to examine MCU processing by Calcium, 8 hours after 
transfection, HEK293 cells were incubated with 2µM ionomycin for 10 minutes, and immediately fixed 
by 4% paraformaldehyde. DIV 14 primary neurons were used for immunocytochemistry, followed by 
identical immunostaining procedure. In case of endogenous MCU staining, coverslips were incubated 
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with -20˚C methanol in the fixation step.  
Co-immunoprecipitation and Western blotting. For Co-immunoprecipitation, 14 hours after 
transfection HEK293 cells were lysed using 400µl of RIPA buffer composed of 150mM NaCl, 50mM 
Tris-HCl, pH 7.4, 1% Triton-X, 0.1% SDS, 0.05% C24H39NaO4 and protease inhibitor cocktail. After 
the Bradford assay (BioRad) was performed for measuring protein concentration, 1mg of proteins were 
incubated with 0.3µl of anti-Flag antibody (Sigma, F7425) or 1µl of anti-Myc antibody (Santa Cruz, 
9E10) on rotator at 4°C overnight. On the next day, protein A/G agarose beads (ThermoFisher, #20421) 
were added to the protein-Ab mixtures, and incubated on rotator for at least 4 hours at 4°C. The 
Immunoprecipitated protein-bead complex was then washed with 1ml of the RIPA buffer, and 
centrifuged for 5 minutes at 5,000×g at 4°C. Supernatant after the centrifugation was then removed. 
After repeating the washing five times, Immunoprecipitated proteins are eluted with SDS loading dye 
by heating for 15 minutes at 95 °C. 
For western blotting, SDS-PAGE gel composed of 4% stacking gel and 12% running gel was used to 
separate proteins. And these proteins were then transferred to a PVDF membrane (Millipore, 
#IPVH00010). Primary antibodies (Anti-Flag Ab; 1:3000, Anti-Myc Ab; 1:1000) diluted in 5% skim 
milk in 1×TBST (0.01% Tween 20) were incubated with the membrane at 4°C overnight. On the next 
day, the membrane was washed three times with 1×TBST for 10 minutes at room temperature, followed 
by the incubation with the secondary antibody diluted as 1:2500 in 5% skim milk in 1×TBST for 1 hour 
30 minutes at room temperature. The membrane was then washed five times with 1×TBST for 10min 
at room temperature. ImageQuant LAS 4000 (GE Healthcare) was used for western blot imaging  
Confocal Microscopy. Zeiss LSM 780 confocal microscope was used for all confocal images. For 
live image, a heating instrument was used for maintaining 37°C, and the Zeiss Definite Focus z-
correction hardware was used for axial stability. A Plan-Apochromat 63×/1.4 oil immersion objective 
(Zeiss 420782-9900-000) was used for all immunocytochemistry images. For FRET experiment, Alexa 
488 and Alexa 555 were used as the donor and acceptor, respectively. For isolated mitochondrial images, 
Individual mitochondrion was acceptor photo-bleached using a 561 nm laser over the course of 20 
frames. 
Calcium Measurements. N2A cells were transfected with the vectors of interest, R-GECO, and 
Mito-GEM-GECO, and incubated for at least 48 hours. For calcium measurement, a C-Apochromat 
40x/1.2 Water Corr M27 objective (Zeiss 421767-9970-000) was used. Cells were imaged for at least 
20 frames at 7 seconds intervals before and after treatment of 2μM ionomycin. R-GECO was used for 
confirming cytoplasmic calcium spike. For mitochondrial calcium measurement, blue-green emission 
ratiometric Mito-GEM-GECO was measured to calculate mitochondrial calcium level. All data was 
obtained from at least 3 experiments performed on cell passages and separate days. To calculate the 
relative calcium change, the calcium level before the treatment of 2μM ionomycin was considered as 
the initial value and baseline.   
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Velocity Measurements. Mitochondrial velocity in axons was calculated as described previously40. 
Mito-dendra2 plasmid vector was transfected into primary hippocampal neurons at DIV4. Experiments 
were performed at DIV13-17. One neuron per glass bottom dish was only subjected to live imaging. 
Each data was obtained from 2-5 independent primary neuron cultures. 405nm laser was used to make 
photo-converted mitochondria in cell body. Mitochondrial movement is observed using a Plan-
Apochromat 20×/0.8 objective (Zeiss 420650-9901-000) in a 708μm × 708μm field of view for 1 hours 
at 15 seconds intervals. A kymograph was generated using data imported into Fiji software. MATLAB 
was used for generating a velocity distribution histogram. The histogram was fitted to a derived Fokker-
Planck equation using Excel software. Real Stats Microsoft Excel plugin was used for Kolmogorov-
Smirnov test. 
Statistics. Dunnett’s, Tukey’s, and Fisher’s LSD ANOVA, two-tailed Student’s t-test, and paired 



























1. MCU interacts with Miro1 through MCU’s N-terminal domain. 
In the previous publication from our group, we reported the mitochondrial matrix Ca2+ content 
regulated by MCU complex is critical for the mitochondrial mobility in axons20. Furthermore, we found 
Miro1 plays a key role in modulating Ca2+ uptake into the mitochondrial matrix20. These results suggest 
a possibility of functional coupling between MCU and Miro1 in a single complex. In order to test this 
possibility, Co-immunoprecipitation assay was performed using anti-Flag antibody or anti-Myc-
antibody. We used plasmid vectors expressing MCU-Flag and Myc-Miro1 for the transfection into 
HEK293 cells (Figure 3A, B). And then, the co-transfected cells were collected and lysed by stringent 
RIPA buffer that allows these two mitochondrial membrane proteins, MCU and Miro1, to completely 
dissociate from the membranes41. As a result, we found MCU biochemically interacts with Miro1, and 
MCU was blotted at the position of 35kDa and 40kDa on a membrane (Figure 3C). Interestingly, we 
observed Miro1 has a significantly biased interaction with the upper 40kDa of MCU (Figure 3C). It is 
noted that MCU contains mitochondrial targeting sequence within its N-terminal domain subjected to 
a proteolytic cleavage following by the mitochondrial localization of MCU21. To further investigate 
whether Miro1 specifically interacts with MCU having N-terminal domain, we designed a vector 
expressing MCU mutant having deletion of N-terminal domain, MCU(∆ 2-57a.a.) (Figure 3A). Co-
immunoprecipitation assay using HEK293cells transfected with either MCU-Flag or MCU(∆2-57a.a.)-
Flag, and Myc-Miro1 was proceeded. The result obviously showed the deletion of the MCU’s N-
terminal domain abolishes its binding to Miro1 (Figure 3D). It suggests a possibility of new MCU’s 
topology in mitochondrial membrane, in which MCU’s N-terminus is projected toward the 
intermembrane space side of IMM. Next, to exclude the possibility that other regions of MCU are able 
to interact with Miro1, we selected mutation sites on the DIME motif of MCU because DIME motif is 
exposed to mitochondrial intermembrane space, forming the pore entrance42. Thus, we designed vectors 
expressing MCU mutants having alteration in several amino acids of the DIME motif, MCU(mutant1) 
and MCU(mutant2), for protein overexpression in HEK293 cells (Figure 3A). Co-immunoprecipitation 
assay was performed using HEK293 cell extracts with anti-Flag antibody. The result showed both MCU 
mutants still remain bound to Miro1, suggesting the DIME motif of MCU is not the region responsible 
for the interaction with Miro1 (Figure 3E). Furthermore, we tried to identify a region in Miro1 needed 
for the interaction with MCU. Expression vectors containing Miro1 without transmembrane domain, 
Miro1(∆ TM), or last 3a.a. beyond TM, Miro1( ∆ KQR), were prepared for the transfection into 
HEK293cells (Figure 3B). The result of co-immunoprecipitation assay showed the deletion of Miro1’s 
transmembrane domain eliminates the interaction between MCU and Miro1, while the deletion of 3 a.a. 
of Miro1 does not affect its binding to MCU (Figure 3F). It suggests the transmembrane domain of 
Miro1 is a key region required for the interaction with MCU. 
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Although co-immunoprecipitation assay is an appropriate method to verify physiologically relevant 
MCU-Miro1interaction, this assay, as in vitro biochemical methods, has difficulty to identify their 
interaction in intact mitochondria. Thus, we additionally performed FRET measurement by acceptor 
photobleaching with isolated mitochondria (Figure 3G). FRET efficiency of Flag-MCU and Myc-Miro1 
was significantly higher than that of either Flag-MCU and TOMM20-Myc or Flag-MCU(∆2-57a.a.) 
and Myc-Miro1, while Flag-MCU(mut1) having the mutation on DIME motif and Myc-Miro1 had 
similar level of FRET efficiency compared to that of Flag-MCU and Myc-Miro1 (Figure 3G). These 
results are consistent with the analysis of co-immunoprecipitation assay showing that Miro1 interacts 
with MCU through its N-terminal domain, not DIME motif. Together, these data indicate MCU and 
Miro1 exist in a single functional complex in mitochondria, and MCU’s N-terminal domain is essential 




Figure 3. Interaction between MCU and Miro1. (A) Schematic representation of MCU domains and 
mutants. MCU proteins having the deletion of N-terminal domain (∆ 2-57a.a.), or mutations on the 
DIME motif (257EYSW260 to 257AAAA260 or 261DIME264 to 261AAAA264) are used for domain mapping. 
(B) Schematic representation of Miro1 domains and mutants. Miro1 proteins without 3a.a. (∆KQR) or 
transmembrane domain (∆TM) are used in mapping analysis. (C) Co-immunoprecipitation of MCU-
Flag and Myc-Miro1. Protein extracts from MCU-Flag and Myc-Miro1 co-transfected HEK293 cells 
were immunoprecipitated by anti-Flag or Myc antibody conjugated with agarose A/G beads. The 
precipitate was subjected to western blotting with indicated antibodies. Interaction between MCU and 
Miro1 was observed. Interestingly, Myc-Miro1 preferentially binds to the unprocessed 40kDa band of 
MCU. (D) Co-immunoprecipitation of MCU(∆2-57a.a.)-Flag and Myc-Miro1. Proteins produced from 
MCU(∆2-57a.a.)-Flag expression vector was only detected on the processed 35kDa band of MCU. The 
binding to Myc-Miro1 was not observed. (E) Co-immunoprecipitation of Myc-Miro1 and MCU-Flag 
mutants. The interaction between MCU and Miro was not affected by mutations on the DIME motif 
(Mutant 1,2). (F) Co-immunoprecipitation of MCU-Flag and Myc-Miro1 mutants. Miro1 mutant having 
TM domain deletion (∆TM) did not interact with MCU, while mutant Miro1 lacking 3a.a (∆KQR) still 
remained bound to MCU. (G) FRET analysis of Flag-MCU and Myc-Miro1 in extracted mitochondria. 
FRET efficiency of Flag-MCU + Myc-Miro1 was significantly higher than that of Flag-MCU + 
TOMM20-Myc. Mutant on DIME motif (Mutant1) of MCU did not affect the binding to Miro1. The 
deletion of MCU’s N-terminal domain (∆2-57a.a.) significantly reduced the interaction between MCU 
and Miro1. Scale bar: 1μm. Tukey’s box plot profile is shown. N= 72 mitochondria for Flag-MCU + 
TOMM20-Myc, 78 for Flag-MCU + Myc-Miro1 25 for Flag-MCU(mutant1) + Myc-Miro1, 23 for Flag-






2. N-terminus of MCU has a transmembrane domain, which doesn’t have a critical role in 
mitochondrial targeting signal. 
Miro1’s biased interaction with the N-terminal domain of MCU provided us with a question about 
roles of MCU’s N-terminal domain in mitochondria. Previous research observed the molecular weight 
of MCU is lower than the predicted 40kDa21, and is consistent with the predicted mitochondrial 
targeting sequence (p=0.976) in this domain which is proteolytically cleaved after mitochondrial 
localization43. However, the recently developed method for improved prediction of mitochondrial 
targeting sequence, MitoFates software, predicts non-presence of the mitochondrial targeting sequence 
in MCU’s N-terminal domain because of lack of positively charged amphiphilicity α helix in the 
domain44,45 (Figure 4A). Thus, we investigated whether this N-terminal domain indeed has a critical 
role in mitochondrial localization of MCU. To test this question, we cultured hippocampal primary 
neurons for co-transfection of either MCU-Flag or MCU(∆2-57a.a.)-Flag and Myc-Miro146. We found 
MCU mutant lacking the N-terminal domain and Myc-Miro1 are co-localized in axons in axons of 
primary neurons as well as MCU-Flag and Myc-Miro1, suggesting this domain is not required for 
targeting MCU into mitochondria. (Figure 4B). This result was further confirmed by using vectors 
expressing N-terminal domain of MCU coupled to superfolder GFP (sfGFP) and Mito-mCherry. The 
immunostaining analysis revealed MCU(1-57a.a.)-sfGFP and Mito-mCherry are not co-localized in 
axons of primary neurons, supporting N-terminal domain of MCU does not act as mitochondrial 
targeting sequence. (Figure 4B). 
The next question is how MCU’s N-terminal domain is interacts with Miro1, the outer mitochondrial 
membrane protein. Current putative topology of MCU has described both MCU’s N and C-terminus are 
projected toward mitochondrial matrix24, providing the low possibility of its binding to Miro1’s 
transmembrane domain. However, the predictive analysis using TMBASE showed MCU’s N-terminus 
has a potential transmembrane domain (18-38a.a.)47, implying the possibility of new topology of 
unprocessed MCU with the data in Figure 3D. To explore this possibility experimentally, we prepared 
two vectors expressing Flag-tagged either N-terminus or C-terminus of MCU, and transfected these 
vectors with Myc-Miro1 into HEK293cells for comparison between staining patterns of Flag-MCU and 
that of MCU-Flag. We observed the Flag-MCU signal is overlapped with Myc-Miro1, a marker for the 
outer mitochondrial membrane. In contrast, the MCU-Flag signal is localized inside of Myc-Miro1 
signal (Figure 4C). To better verify the topology of N-terminus of MCU, we isolated mitochondria from 
either Flag-MCU or MCU-Flag and Myc-Miro1 co-transfected HEK293 cells. The result showed more 
obvious difference than the data in Figure 4C, suggesting MCU’s N-terminus is projected toward the 
outer mitochondrial membrane for the interaction with Miro1 (Figure 4D). 
Then, a question is raised from results showing MCU’s N-terminus projected toward the OMM and 
its binding to the transmembrane domain of Miro1 (Figure 3F). The question is whether N-terminus of 
MCU penetrates the OMM to reach Miro1’s transmembrane domain. To solve this question, we 
18 
extracted mitochondria from HEK293 cells transfected with Flag-MCU and Mito-GFP, followed by 
treatment of proteinase K which selectively digests proteins or peptides projected toward the 
cytoplasmic side of the outer mitochondrial membrane. Proteinase K efficiently digested not only 
TOMM20, the outer mitochondrial membrane protein, but also Flag-tag at N-terminus of MCU. 
Whereas Intact mitochondria protected Mito-GFP, located inside the mitochondrial matrix, and 
cytochrome C, located within intermembrane space, from the digestion by proteinase K (Figure 4E), 
confirming MCU’s N-terminus is able to extend out from the OMM and localized on the cytoplasmic 
side of this membrane. These results are consistent with the analysis using TMBASE that showed a 
predicted hydrophobic path (1-13a.a.) at the tip of MCU’s N-terminus with the potential transmembrane 
domain (18-38a.a.) (Figure 4A). Together, these data revealed N-terminal domain of MCU is not 













Figure 4. Identification of topology of N-terminus of MCU. (A) Schematic domain of MCU. The N-
terminal domain of MCU involves a predicted hydrophobic patch (1-13a.a.) and transmembrane domain 
(18-38a.a.). (B) Immunostaining of Myc-Miro1 with MCU-Flag, MCU(∆2-57a.a.)-Flag, or MCU(1-
57a.a.)-sfGFP in axons of hippocampal primary neurons. MCU’s N-terminal domain (1-57a.a.) is not 
sufficient to target MCU to mitochondria. Scale bar: 10μm. (C, D) Immunostaining of Flag-MCU or 
MCU-Flag with Myc-Miro1 in N2A cells and mitochondria isolated from HEK293 cells. The 
fluorescent signal of Flag-MCU, not MCU-Flag, is highly colocalized with that of Myc-Miro1. Scale 
bar: 1μ m. (E) Proteinase K treatment in mitochondria isolated from Mito-GFP and Flag-MCU co-
transfected HEK293 cells. The fluorescent signal of Flag-MCU and TOMM20 were disappeared by 
proteinase K treatment, while that of Cytochrome C and Mito-GFP was still shown. Scale bar: 1μm. 
Bar graph represents quantification of samples. N= 96 mitochondria for TOMM20 without proteinase 
K, 51 for TOMM20 with proteinase K, 43 for Cytochrome C without proteinase K, 82 for Cytochrome 






3. Intracellular Ca2+ elevation results in the cleavage of MCU’s N-terminal domain. 
MCU exists in two different forms, unprocessed MCU with the N-terminal domain, and processed 
MCU lacking this domain21. And we demonstrated the N-terminal domain of unprocessed MCU is able 
to interact with Miro1 within mitochondria. Then, we next asked which factors influence the interaction 
between MCU and Miro1. We hypothesized intracellular Ca2+ elevation triggers the cleavage of MCU’s 
N-terminal domain, resulting in eliminating its interaction with Miro1. The reason why we choose Ca2+ 
is that it acts as a key molecule to regulate functions of both the MCU complex and Miro1 through 
binding to them17. To investigate this hypothesis, we designed a vector expressing Flag and sfGFP 
tagged at N-terminus and C-terminus of MCU, respectively. The location of these tags in Flag-MCU-
sfGFP expressing HEK293 cells was investigated with and without treatment of 2μM ionomycin, a Ca2+ 
ionophore, for 10min48. Immunostaining Images showed both Flag and sfGFP signals are clearly 
colocalized within mitochondria without 2μM ionomycin treatment. However, Flag-tagged at MCU’s 
N-terminus was distributed to the cytoplasm, while the sfGFP signal was still colocalized with 
mitochondria (Figure 5A). R2 correlation analyzed from these images revealed a significant decrease in 
2μM ionomycin treatment compared to DMSO treatment. It suggests the Ca2+ elevation stimulates the 
cleavage of N-terminal domain of MCU to disrupt the interaction between MCU and Miro1. 
Furthermore, we tried to confirm the cleavage of this domain through the western blotting. MCU-Flag 
expressed HEK293 cells were exposed to 2μM ionomycin before the steps for protein extraction. The 
result showed a decrease in the intensity of unprocessed MCU, and the ratio of unprocessed to processed 
MCU was also significantly decreased (Figure 5B). 
Based on these results, we represented the MCU-Miro1 interaction model depicted in Figure 5C. In 
the model, MCU’s N-terminal domain has the third transmembrane domain (TM3) that protrudes into 
the intermembrane space and hydrophobic patch to reach the Miro1’s transmembrane domain, 
providing the new topology of MCU. Due to the new MCU topology, the interaction between MCU and 
Miro1 is maintained under a normal Ca2+ level. However, elevated intracellular Ca2+ initiates the 
cleavage of MCU’s N-terminal domain, forming the previously established structure of MCU. This 
MCU structure does not allow it to interact with Miro1 (Figure 5C). 
 
 
Figure 5. Cleavage of N-terminal domain of MCU by the elevated intracellular calcium. (A) 
Immunostaining of Flag-MCU-sfGFP after incubation with ionomycin in HEK293cells. Flag-tag and 
sfGFP were coupled to N-terminus and C-terminus of MCU, respectively. Flag-MCU-sfGFP transfected 
HEK293cells were incubated for 10min with 2μM ionomycin, followed by fixation. Scale bar: 5μm. 
The R2 correlation between Flag and sfGFP was compared between paired samples with or without 
ionomycin treatment. N= 5 experiments. *p= 0.0171. (B) Western blot data of MCU-Flag with 














(Figure legend continued.) extracted from HEK293cells transfected with MCU-Flag, and then blotted 
with anti-Flag antibody. The ratio of unprocessed MCU (Upper band) to processed MCU (Lower band) 
is displayed as Tukey’s boxplot profile. N= 7 experiments. **p= 0.0094. (C) Model of MCU and Miro1. 
MCU’s N-terminal domain has the third transmembrane domain that allow it to locate toward the 
cytoplasmic side of the outer mitochondrial membrane. Under the normal condition, cleavage of the N-
terminus of MCU is not occurred, allowing it to maintain the interaction with the transmembrane 
domain of Miro1. However, intracellular Ca2+ elevation triggers the cleavage of N-terminal domain of 
MCU, resulting in loss of MCU-Miro1 interaction. 
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4. MCU-Miro1 interaction is essential for mitochondrial mobility in axons. 
Having demonstrated that MCU and Miro exists in the single complex through the interaction 
between them, we next asked whether their interaction functionally regulates Ca2+ uptake through MCU 
and axonal mitochondrial movement by Miro1. To test this question, we designed a vector expressing 
MCU in which two consecutive amino acids in its N-terminus (R7A,S8A) were mutated because it is 
known that arginine, as a positively charged amino acid, acts as a gating charge carrier49. Interestingly, 
Co-immunoprecipitation assay with Myc-Miro1 revealed this mutant is present in the only 40kDa band 
of unprocessed MCU, and still interacts with Miro1 (Figure 6A). Thus, MCU(R7A,S8A)-Flag was also 
used to understand functional roles of MCU-Miro1 interaction. 
To examine whether this interaction indeed modulate mitochondrial Ca2+ uptake through MCU 
complex. We used N2A cells transfected the genetically-encoded Ca2+ indicators (R-GECO and mito-
GEM-GECO)50, shMCU for knock-down of MCU, and either MCU-Flag or MCU mutants. Baseline of 
Ca2+ level was measured for at least 100sec before the addition of 2μM ionomycin. Intracellular Ca2+ 
elevation following treatment with ionomycin was confirmed by the cytoplasmic Ca2+ indicator, R-
GECO. Mitochondrial Ca2+ level was monitored using the mitochondrial Ca2+ indicator, mito-GEM-
GECO. As previously known21,22. We found MCU knock-down reduces mitochondrial Ca2+ uptake, and 
the mutation on DIME motif impairs the mitochondrial Ca2+ uptake. In contrast, Expression of MCU-
Flag or MCU(∆2-57a.a.)-Flag restored Ca2+ uptake reduced by MCU knock-down. We further found 
the expression of MCU(R7A,S8A)-Flag was not able to rescue Ca2+ influx to that of control (Figure 6B, 
C). Together, these data suggest the cleavage and dissociation of MCU’s N-terminal domain from Miro1 
is critical for the efficient Ca2+ uptake through MCU complex. 
Next, we measured the number of mitochondria leaving cell body of neurons to understand a 
functional significance of the interaction in axonal mitochondrial movement. Both neurons expressing 
shMCU and MCU(∆ 2-57a.a.)-Flag with shMCU showed a significantly decrease in the number of 
mitochondria leaving cell body compared to that of control and MCU-Flag with shMCU (Figure 6D), 
suggesting N-terminal domain of MCU interacting with Miro1 is essential for mitochondrial movement 
from cell body to axon. We also tested with neurons expressing MCU(R7A,S8A)-Flag with shMCU. 
The number of mitochondria leaving cell body in them was too small to measure enough mitochondrial 
mobility in axons (Figure 6D). It suggests this MCU mutant may act as a dominant-negative form that 
interrupts normal interaction between MCU and Miro1 to modulate the mitochondrial movement. To 
further analyze the mitochondrial movement regulated by MCU-Miro1 interaction, we used the 
kymograph analysis using a photo-switchable fluorescent protein, mito-dendra2, labeled mitochondria 
in axons51 (Figure 6E). And, photoconverted mitochondria were only subjected to this analysis. Velocity 
distribution of mitochondrial movement was then fitted by a modified Fokker-Plank equation40, 
providing improved representation of axonal mitochondrial mobility by eliminating bias toward axon 
areas with minimal movement activity. We found that MCU knock-down reduces the velocity of mobile 
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mitochondria in axon. The reduced velocity caused by MCU knock-down was restored by expression 
of MCU-Flag, while MCU(∆2-57a.a.)-Flag cannot rescue the reduced mitochondrial velocity in axons 
(Figure 6F, G). Together, these results imply MCU-Miro1 interaction is critical for maintaining the 
axonal mitochondrial mobility; however, cleavage of MCU’s N-terminus and elimination of this 










Figure 6. Axonal mitochondrial movement and Ca2+ influx capability altered by MCU-Miro1 
interaction. (A) Co-immunoprecipitation of MCU(R7A,S8A)-Flag and Myc-Miro1. N-terminal 
domain of MCU(R7A,S8A)-Flag is not cleaved, and still interacts with Myc-Miro1. (B) Quantification 
of Ca2+ influx into mitochondria in N2A cells after 2μ M ionomycin treatment. N2A cells were 
transfected with R-GECO and Mito-GEM-GECO as cytoplasmic and mitochondrial Ca2+ indicator, 
respectively. shCtrl, shMCU, shMCU + MCU-Flag, shMCU + MCU(∆2-57a.a.)-Flag, or shMCU + 
MCU(R7A,S8A)-Flag were co-transfected with Ca2+ indicators. A single ANOVA test was applied to 
statistics. (C) Quantification of the Mito-GEM-GECP ratio at the first frame after exposing N2A cells 
to 2μM ionomycin. One-way ANOVA Dunnett’s multiple-comparison test. Tukey’s box plot profile is 
shown. N= 12 N2A cells for shCtrl, 12 for shMCU, 11 for shMCU + MCU-Flag, 12 for shMCU + 
MCU(∆ 2-57a.a.)-Flag, 8 for shMCU + MCU(mut1)-Flag, 12 for shMCU + MCU(R7A,S8A)-Flag. 
*p<0.01, ****p<0.0001. (D) The number of Mito-dendra photoconverted mitochondria leaving cell body 
per hour in hippocampal primary neurons. One-way ANOVA Dunnett’s multiple-comparison test. 
Tukey’s box plot profile is shown. N= 9 neurons for shCtrl, 12 for shMCU, 9 for shMCU + MCU-Flag, 
5 for shMCU + MCU(∆2-57a.a.)-Flag, 5 for shMCU + MCU(R7A,S8A)-Flag. *p<0.01, ****p<0.0001. 
(E) Kymograph of axonal mitochondrial movement in hippocampal primary neurons. Mito-dendra 
labeled mitochondria in cell body were photoconverted to red color to allow tracking of mitochondria 
moving from the cell body toward the axon. Green colored mitochondria were already located in the 
axon. Images were acquired every 15 seconds for 1 hour. Horizontal scale bar: 50μm. Vertical scale bar: 
10 minutes. (F) Velocity distribution of axonal mitochondria fitted to a derived Fokker-Planck equation. 
(G) Cumulative probability graph derived from the data in (F). Kolmogorov-Smirnov test was 







In this study, we discovered a novel MCU-Miro1 interaction. The N-terminal domain of MCU is a 
key region for interacting with Miro1, providing this domain with alternative functions that are different 
from a previously putative function as mitochondrial targeting sequence. We found this N-terminal 
domain is dispensable for targeting MCU to mitochondria. The interaction through the N-terminal 
domain rather proposes a model depicting new MCU topology within mitochondria. We also showed 
that dissociation of the interaction is caused by the cleavage of MCU’s N-terminus in response to the 
intracellular Ca2+ elevation, and this cleavage is required for efficient Ca2+ uptake through MCU. We 
identified the MCU-Miro1 interaction is needed for efficient mitochondrial movement in axons. 
Although we clearly observed the MCU and Miro1 interaction both biochemically and visually, there 
was a limitation that all evidences were demonstrated using the overexpression of MCU and Miro1 
proteins. A critical issue in this study is whether the amount of endogenous MCU having N-terminal 
domain is enough to regulate the mitochondrial movement in the total amount of MCU. Unfortunately, 
we did not confirm clearly the interaction between endogenous MCU and Miro1, because the majority 
of MCU protein endogenously exists in the cleaved form lacking N-terminal domain21. However, a 
recent structural analysis of MCU revealed it forms a pore complex through the pentameric 
oligomerization24, and our proposed model indicates that Miro1 is able to interaction with a single 
unprocessed MCU protein out of five in the complex, suggesting the low expression of unprocessed 
MCU is enough to regulate the mitochondrial transport. Moreover, mobile mitochondria become 
stationary as neurons mature, and eventually only 20-30% of mobile mitochondria are found in a typical 
neuron20, that is consistent with a lowered presence of the unprocessed form of MCU. 
Another issue is that while the interaction regulated by Ca2+ dependent cleavage is irreversible, 
mitochondrial mobility is reversible52. Given that neurons frequently respond to sudden changes in their 
internal and external signals, and mitochondria also rapidly sense and respond to their demand53, our 
model may be required for rapid arrest of mitochondrial movement upon a high pulse of Ca2+, and the 
resumption of mitochondrial movement may be compensated by other mitochondrial transport 
machineries. 
In summary, we found the novel functional coupling between MCU and Miro1 to regulate 
mitochondrial Ca2+ uptake and transport in neurons, and demonstrated they share a molecular 
mechanism modulating these mitochondrial functions. It will be interesting for future studies to 
investigate enzymes and detailed mechanisms responsible for regulating MCU cleavage in response to 
the Ca2+ elevation. Also, our finding will help to understand dysfunctions of mitochondrial transport 
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